Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 3 days agoOne reason for Moderna’s low sales is because Americans aren’t getting booster vaccines as...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 4 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 4 days agoThe Covid vaccine maker came out of the March quarter with a $3.07 loss per share, reversing from a...
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 3 days agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year....
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 3 days agoModerna is rivaling vaccine makers Pfizer and Novavax. Still, the market for Covid boosters is...
EXPLAINER: Boosters key to fight omicron, lot still to learn
AOL· 4 days agoThe new omicron variant took only a few weeks to live up to dire predictions about how hugely...
A Better Concept For mRNA Vaccines: Self-Amplification
Forbes· 7 days agoTwo new self-amplifying mRNA vaccines herald a new era of vaccination for coronaviruses.